ArticleInternal medicine (Tokyo, Japan)2025
Response to Letter to the Editor: "In Patients Receiving Pembrolizumab, Adverse Effects on the Pituitary Gland, Heart and Kidneys Must Be Excluded".
Saori InouePubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.